All News #Library
Biotech
JPM26: Kalvista`s HAE Win Is A `Tale Of Two Markets`
21 Jan 2026 //
BIOSPACE
KalVista Gets CHMP Nod for Sebetralstat in Hereditary Angioedema
25 Jul 2025 //
BUSINESSWIRE
KalVista sells Japanese rights for HAE drug to Kaken
08 Apr 2025 //
BUSINESSWIRE
KalVista Appoints Brian Piekos as Chief Financial Officer
10 Sep 2024 //
BUSINESSWIRE

Market Place
Sourcing Support